SS Innovations International, Inc. (NASDAQ:SSII) Short Interest Update

SS Innovations International, Inc. (NASDAQ:SSII) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totaling 49,199 shares, a decrease of 34.0% from the April 15th total of 74,555 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 39,585 shares, the days-to-cover ratio is presently 1.2 days.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on SSII. Wall Street Zen raised SS Innovations International from a “sell” rating to a “hold” rating in a research note on Saturday. Weiss Ratings reissued a “sell (e+)” rating on shares of SS Innovations International in a research note on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Insider Transactions at SS Innovations International

In related news, Director Frederic H. Moll acquired 501,253 shares of the stock in a transaction dated Friday, March 6th. The stock was purchased at an average cost of $3.99 per share, with a total value of $1,999,999.47. Following the completion of the purchase, the director directly owned 10,775,485 shares in the company, valued at $42,994,185.15. This trade represents a 4.88% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Srivastava Sudhir acquired 498,753 shares of the stock in a transaction dated Friday, March 6th. The stock was bought at an average cost of $4.01 per share, with a total value of $1,999,999.53. Following the completion of the purchase, the chief executive officer owned 109,851,767 shares of the company’s stock, valued at approximately $440,505,585.67. The trade was a 0.46% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 1,300,006 shares of company stock valued at $5,196,999 over the last ninety days.

Hedge Funds Weigh In On SS Innovations International

Several institutional investors and hedge funds have recently bought and sold shares of SSII. Geode Capital Management LLC bought a new position in SS Innovations International during the second quarter valued at $122,000. Envestnet Asset Management Inc. bought a new position in SS Innovations International during the third quarter valued at $71,000. PNC Financial Services Group Inc. bought a new position in SS Innovations International during the third quarter valued at $56,000. Handelsbanken Fonder AB bought a new position in SS Innovations International during the third quarter valued at $714,000. Finally, JNBA Financial Advisors bought a new position in SS Innovations International during the fourth quarter valued at $498,000.

SS Innovations International Price Performance

SSII stock opened at $3.86 on Monday. The firm has a market cap of $772.50 million and a PE ratio of -77.20. The business has a 50 day moving average of $4.58 and a 200-day moving average of $5.25. SS Innovations International has a 12-month low of $3.02 and a 12-month high of $11.87.

SS Innovations International (NASDAQ:SSII) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.02) earnings per share for the quarter. SS Innovations International had a negative net margin of 20.69% and a negative return on equity of 23.00%. The firm had revenue of $11.10 million for the quarter.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.